Abstract
Recent experimental studies have found that photodynamic therapy (PDT) combined with programmed death receptor 1 (PD-1)/programmed cell death-Ligand 1 (PD-L1) inhibitors can effectively inhibit in situ tumor growth and prevent tumor recurrence and metastasis, and has emerged as a new therapeutic option. However, clinical data is still limited.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
